Sökresultat

Jan de Boer is a biologist at the department of Biomedical Engineering, Eindhoven University of Technology in The Netherlands. His research interest is in the molecular complexity of cells and how molecular circuits are involved in cell and tissue function. His research is characterized by a holistic approach to both discovery and application, aiming at combining high throughput technologies, comp

https://www.pi.lu.se/en/article/meet-our-new-guest-researcher-jan-de-boer - 2025-12-29

Gifted and enthusiastic students work with the "layers of history" in our beautiful Sculpture Hall. Pufendorf IAS is situated in one of the most beautiful buildings in Lund (if we may say so ourselves), originally built in 1886. The last major renovation of the former Department of Physics and Classical Department was done in 2009, just before the Pufendorf Institute moved in. It was of great impo

https://www.pi.lu.se/en/article/welcome-back-classical-archaeology-and-ancient-history - 2025-12-29

At yesterday’s meeting, the board of Pufendorf IAS decided to invite four new Themes to the institute this fall. We received ten theme applications in December 2023, six of these were sent on to external experts for review and four of these are now invited to start in September 2024. The chosen Themes are (in no particular order):Theme: DigitaxToday’s principles for taxation requires that value cr

https://www.pi.lu.se/en/article/four-new-themes-during-2024-2025 - 2025-12-29

Özlem Çelik is currently visiting the Pufendorf IAS as part of a new exchange programme of NordIAS´s fellows. She is a visiting scholar at the University of Helsinki and a Senior Researcher at the Department of Social Research, University of Turku and Turku Institute for Advanced Studies (TIAS) Collegium Fellow. You were a postdoc at Lund University in 2018-2019, welcome back to Lund! You have bee

https://www.pi.lu.se/en/article/welcome-back-ozlem-celik - 2025-12-29

Today, on the 17 of June, the board of the Pufendorf IAS decided to accept three applications to form three new Advanced Study Groups - all starting in September 2024! These ASGs will pursue interdisciplinary research ideas within Oaths and Courts – from Forum to the Future;Neobiogenesis: The Inevitability of Life; Next Generation Healthscapes: Interdisciplinary Approaches to Care Facilities of th

https://www.pi.lu.se/en/article/three-new-advanced-study-groups-and-five-new-themes-2024-2025 - 2025-12-29

The Pufendorf IAS stimulates interdisciplinary research within Lund University. The Institute supports researchers working together across disciplinary borders to develop new areas of research. The Institute announces yearly calls for application to Themes and Advanced Study Groups. Researchers/teaching staff (with PhD or equiv.) employed by Lund University are now invited to apply for Themes and

https://www.pi.lu.se/en/article/call-applications-pufendorf-institute-advanced-studies - 2025-12-29

Every four years, the Pufendorf Institute for Advanced Studies is evaluated to monitor how the institute meets its overall objectives and follows its basic principles. This year, an external panel has evaluated the activities during the years 2018–2021 (yes, including the pandemic years), the model on which the Pufendorf Institute rests and what makes the institute unique. The panel consisted of M

https://www.pi.lu.se/en/article/pufendorf-institutes-sustainable-principles - 2025-12-29

A couple of weeks have passed since our symposium: Conducting research in interdisciplinary teams. On the 21 of October, we had the great pleasure of welcoming both Martin Cloonan and Britta Padberg, two of our external evaluators, back to Lund. And both were kind enough to speak at the Symposium. Martin Cloonan led with taking the audience back to May 2024 and the work the external evaluators did

https://www.pi.lu.se/en/article/constructive-friction-context - 2025-12-29

Cellist Andreas Brantelid is today one of the most sought after soloists from Scandinavia, and has received overwhelming reviews for his thoughtful interpretations, his most personal colored tone, and not least with his engaging personality. In early September he was employed as a Senior Lecturer in cello at the Malmö Academy of Music. Andreas Brantelid has performed throughout the world, with pro

https://www.mhm.lu.se/en/article/andreas-brantelid-new-senior-lecturer-cello - 2025-12-29

A new joint report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) presents the largest venture ever on precision medicine in diabetes. The report includes a detailed overview and roadmap for how this new approach to diabetes medicine can be evaluated and implemented into clinical practice. The role of precision diabetes medicine will be t

https://www.ludc.lu.se/article/roadmap-precision-medicine-diabetes-care - 2025-12-29

The research group Nutritional Epidemiology has started a blog, www.nutrition.blogg.lu.se! Esther González-Padilla tells us more about it. ​​​​​What is the blog about?We have started the blog mostly as a tool to inform people, within and outside Lund University, about the news of our group, our projects and activities. But in the future it might also serve as a platform to share and discuss hot to

https://www.ludc.lu.se/article/new-blog-about-nutriton - 2025-12-29

Karin Stenkula, Emily Sonestedt and Sebastian Kalamajski have received grants from the The Bo and Kerstin Hjelt Diabetes Foundation. Read about their research projects here. Karin Stenkula, Lund University Diabetes Centre:EHD2: a novel candidate essential for lipid transport and overall glucose homeostasisObesity is one of the main risk factors behind type 2 diabetes and cardiovascular diseases. B

https://www.ludc.lu.se/article/hjelt-foundations-grant-holders-2020 - 2025-12-29

A new COVID-19 antibody test developed by scientists at Lund University in Sweden has shown robust performance upon clinical validation and application. The test detects antibodies in the blood targeting the spike protein of SARS-CoV-2, and determines in just 15 minutes whether a person has had COVID-19, regardless of whether they have had any symptoms. “Unlike other serological tests to determine

https://www.ludc.lu.se/article/new-rapid-and-robust-covid-19-antibody-test-developed - 2025-12-29

Last week it was announced that our longtime colleague and LUDC researcher/SUS clinician Martin Ridderstråle has been appointed Senior Vice President of Patient Care in the Novo Nordisk Foundation. This is not only a remarkable achievement by Martin but also goes to show that our environment fosters excellent scientists and outstanding clinicians. Martin is one of the most versatile people I know.

https://www.ludc.lu.se/article/senior-vice-president-patient-care-novo-nordisk-foundation - 2025-12-29

Karl Bacos, assistant researcher at LUDC is the recipient of 2020 years Medeon stipend of 50 000 sek for his innovative work within epigenetics in diabetes.   The Medeon stipend is handed out in connection to the acknowledgement of World Diabetes Day in Skåne which takes place on November 14th. This year the arrangement will be broad casted to the public in real time from Medeon Science Park in Ma

https://www.ludc.lu.se/article/karl-bacos-years-recipient-medeon-stipend - 2025-12-29

In many studies, bariatric surgery has been highlighted as an almost magical method for weight loss and reversing type 2 diabetes. One question that has remained largely unanswered is how the effect of surgery differs from the effects of a strict low-calorie diet. This question has now been examined by researchers at Lund University in Sweden in a study published in the journal Diabetes. By monito

https://www.ludc.lu.se/article/strict-diet-explains-metabolic-effect-gastric-pass-surgery - 2025-12-29

Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating. Researchers at Lund University in Sweden have now identified biomarkers that can show in advance how the patient will respond to metformin treat

https://www.ludc.lu.se/article/metformin-type-2-diabetes-patients-or-not-researchers-now-have-answer - 2025-12-29

Should patients with separate variants of type 2 diabetes be treated with different types of drugs? Researchers at Lund University in Sweden and Skåne University Hospital will attempt to answer that question in a new study.   Type 2 diabetes is one of the fastest growing diseases in the world. It is estimated that over 300 million people have the disease globally. “Current treatment methods are un

https://www.ludc.lu.se/article/new-study-personalized-type-2-diabetes-treatment-launched - 2025-12-29

Our latest study on COVID-19 transmission risk among healthcare professionals, a collaboration between Prof Magnus Rasmussen (Dep. of Infection Medicine) and Associate Professor Yang De Marinis (Dep. of Clinical Sciences).  The study was conducted on ~500 healthcare professionals and staff members from 9 units at the Skåne University Hospital in Malmö and Lund, as well as non-medicine related depa

https://www.ludc.lu.se/article/study-covid-19-among-healthcare-professionals - 2025-12-29

Newborn babies are already being screened for mutations and genetic tests help families with hereditary breast cancer. Genomic-driven precision medicine (GDPM) is an emerging approach for disease treatment. Around 30 Swedish researchers suggest a direction forward in a review article in Journal of Internal Medicine (JIM). "At the moment newborns are screened for a small number of mutations. In the

https://www.ludc.lu.se/article/precision-medicine-emerging-approach-complex-diseases - 2025-12-29